ALS Limited (ASX:ALQ) agreed to acquire YORK Analytical Laboratories, Inc. on March 25, 2024. In related transaction, ALS Limited acquired Wessling Holding GmbH & Co. The total cost of the acquisitions is approximately AUD 225 million and will be funded from existing bank debt facilities.

In year 2023, YORK Analytical Laboratories had a revenue of AUD 35 million. ALS has prepared integration plans for employees, clients and stakeholders of both businesses. The acquisition will be effective 1 April 2024.